Progression of renal disease—can we forget about inhibition of the renin–angiotensin system?
- 5 July 2006
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (9) , 2348-2351
- https://doi.org/10.1093/ndt/gfl315
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysisThe Lancet, 2005
- Antihypertensive Agents for Primary Prevention of Diabetic NephropathyJournal of the American Society of Nephrology, 2005
- Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs a DiureticArchives of internal medicine (1960), 2005
- Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trialThe Lancet, 2005
- Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic reviewBMJ, 2004
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal DiseaseAnnals of Internal Medicine, 2001
- Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive NephrosclerosisA Randomized Controlled TrialJAMA, 2001
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- Reduction of proteinuria by angiotensin converting enzyme inhibitionKidney International, 1987